Bladder cancer
Conditions
Interventions
High-grade non-muscle invasive bladder cancer group:None
Low-grade non-muscle invasive bladder cancer group:None
Recurrence and progression group:None
Non-recurrence and non-progression group:None
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1.Patients aged 18 to 90 years. 2.Histopathologically confirmed non–muscle-invasive urothelial carcinoma of the bladder. 3.Availability of at least 3 years of follow-up information. 4.Normal or near-normal function of major organs (heart, liver, lung, and kidney), with a performance status (PS) score of 0–2. 5.Availability of comprehensive clinical and pathological data.
Exclusion criteria
Exclusion criteria: 1.Patients diagnosed with non-urothelial bladder carcinomas, including bladder adenocarcinoma, small cell carcinoma, clear cell carcinoma, carcinoid tumor, or muscle-invasive urothelial carcinoma. 2.Metastatic bladder cancer or cases with secondary bladder involvement from other primary malignancies. 3.Patients who have recently received other investigational or experimental treatments. 4.Patients with severe comorbidities (e.g., cardiovascular disease, hepatic or renal insufficiency) that may affect treatment outcomes. 5.Patients with incomplete pathological data or poor-quality clinical and pathological records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence free survival;Progression-free survival; | — |
Countries
China
Contacts
Public ContactHaitao Liu
Shanghai General Hospital
Outcome results
None listed